Correction: Zanubrutinib combined with R-CHOP in previously untreated diffuse large B-cell lymphoma with specific gene alteration: a phase II study - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Correction: Phase II evaluation of zanubrutinib plus R-CHOP for untreated diffuse large B-cell lymphoma with a specific gene alteration

  • By

  • Qunling Zhang

  • Shiyu Jiang

  • Ran Wei

  • Wenhao Zhang

  • Longlong Bao

  • Yizhen Liu

  • Jia Jin

  • Fangfang Lv

  • Chuanxu Liu

  • Xiaojian Liu

  • Hui Sun

  • Jiachen Wang

  • Rong Tao

  • Xiaoyan Zhou

  • Junning Cao

  • November 5, 2026

Share

Clinical Scorecard: Correction notice: Blood Cancer Journal

At a Glance

CategoryDetail
ConditionNot specified in the correction notice.
Key MechanismsNot described in the correction notice.
Target PopulationNot specified in the correction notice.
Care SettingNot specified in the correction notice.

Key Highlights

  • During correction, the updated version of Fig. 2 was not included in the article.
  • The original article has undergone correction.
  • The correction was published online on 1 July 2026.

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

          Patient & Prescribing Data

          Not specified in the correction notice.

          The correction notice provides no treatment or prescribing details.

          Clinical Best Practices

            Related Resources & Content

            Original Source(s)

            Correction: Zanubrutinib combined with R-CHOP in previously untreated diffuse large B-cell lymphoma with specific gene alteration: a phase II study

            • by Qunling Zhang, Shiyu Jiang, Ran Wei, Wenhao Zhang, Longlong Bao, Yizhen Liu, Jia Jin, Fangfang Lv, Chuanxu Liu, Xiaojian Liu, Hui Sun, Jiachen Wang, Rong Tao, Xiaoyan Zhou, Junning Cao

            • November 5, 2026

            Related Content

            GLP-1 Receptor Agonists and Obesity-Related Cancer by Diabetes Severity

            The first attempts to transplant bone marrow—tribute to Jan Raszek-Rosenbusch and Franciszek Groër.

            The Evidence-Based Cancer Control Programs website – a strategy for disseminating effective interventions